Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve
|
|
- Peregrine Spencer Curtis
- 6 years ago
- Views:
Transcription
1 Original Article Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve Sonal Panchal, Chaitanya Nagori Dr. Nagori s Institute for Infertility and IVF, Ellisbridge, Ahmedabad, Gujarat, India Address for correspondence: Dr. Sonal Panchal, Dr. Nagori s Institute for Infertility and IVF, 2 nd Floor Kedar, Opp. Petrol Pump, Nr. Parimal Garden, Ellisbridge, Ahmedabad , Gujarat, India. E mail: sonalyogesh@yahoo. com Received: Review completed: Accepted: ABSTRACT AIM: This study aims to compare the efficacy of AFC and AMH, as markers for ovarian reserve. MATERIALS AND METHODS: 75 patients with PCO (polycystic ) undergoing IVF were randomized with 75 non PCO patients. On day 3, volume of ovary was acquired, ovarian volume was defined by VOCAL, and Sono AVC was used to count the number of antral follicles. Sum total of antral follicles in both was taken as total antral follicle count (AFC). AMH was measured on the same day. Long agonist protocol with recombinant FSH (rfsh) was used for IVF stimulation till at least two follicles of 18 mm were seen. hcg 10,000 iu was given and ovum pick up was done after h. Primary end point was number of follicles >12 mm seen on day of hcg. Final end point was number of ova retrieved on ovum pick up. Correlation of AFC and AMH was checked for both end points and with each other. RESULTS: Correlation of AFC and follicles >12 mm on day of hcg in PCO group is 0.56 and non PCO group is 0.63, 1 and for AMH and follicles >12 mm on day of hcg in PCO group is 0.42 and non PCO group is Correlation of AFC with number of ova retrieved on OPU in PCO group is 0.44 and for non PCO group is The value for AMH is 0.39 in PCO and 0.43 for non PCO group. Comparing correlation of AFC and AMH for primary end point in PCO group has z value 1.11(onetailed , twotailed 0.267) and in non PCO group comparison shows a z value of 1.39 (one tailed , two tailed ). Therefore in both groups, AFC and AMH correlates with total number of follicles >12 mm on day of hcg, but both AFC and AMH have independent. Comparing correlation of AFC and AMH with number of ova retrieved on OPU, in non PCO group has z value of 0.54(one tailed , two tailed ). In PCO group, this comparison shows, z value of 0.36(one tailed , two tailed ). CONCLUSION: AFC and AMH correlate with each other but have independent for estimating follicles >12 mm on day of hcg. For ova retrieved on OPU, in PCO group, AMH and AFC have similar. In non PCO, AMH may increase accuracy of estimation of number of ova retrieved on OPU over AFC, but difference is not significant. AFC only may suffice for estimation of number of ova retrieved on OPU for all practical purposes. KEY WORDS: Anti-mullerian hormone, antral follicle count, ovarian reserve Access this article online Quick Response Code: Website: DOI: / INTRODUCTION Ovarian reserve relates to secondary, pre antral and antral ovarian follicle pool. Ovarian reserve was conventionally assessed by serum FSH (S. FSH). AMH (Anti mullerian hormone) has lately been found to be a very reliable and more accurate than S.FSH, for assessment of ovarian reserve. Anti mullerian hormone is produced by pre antral follicles. The highest level of AMH expression is present in granulosa cells of secondary, pre antral and small antral follicles up to 6 mm in diameter. [1] Therefore, level of AMH may represent the population of these follicles. It has been shown that the number of antral follicles in the is proportionally related to the size of primordial follicle stock from which they were recruited. [2] Therefore, the antral follicle count (AFC) is believed to represent the quantitative aspect of ovarian aging. [3] With advancement in ultrasound technology it is now possible to count antral follicles. This study was therefore designed to find out if there was any correlation between AFC and AMH and to analyze which of the two is more reliable. Comparison of AMH and AFC has been done in two groups: 274 Journal of Human Reproductive Sciences / Volume 5 / Issue 3 / Sep - Dec 2012
2 Polycystic PCOs and non PCOs (normal ). S. FSH did show high values for low reserve but its values are not found to be different for normal and hyper responding PCO groups. These two groups were selected for the study, therefore to assess whether values of these new markers were different in these groups. OBJECTIVE The study aims to find out whether AFC or AMH is more reliable parameter for assessment of ovarian reserve based on computation of correlation between AFC and AMH. MATERIALS AND METHODS Seventy five patients with PCOs, with BMI (Body mass index) between 22 and 26 (mean 24.5) undergoing IVF (In vitro fertilization) were randomized with 75 patients with same BMI (mean 23.2) but non PCO (normal responding) undergoing IVF (In vitro fertilization) for the study. In both groups, patients recruited were of years of age. Mean age in PCO group was 28.7 years and mean age in non PCO group was 29.2 years. Patients in PCO group were confirmed to have PCO by Rotterdam criteria, whereas patients in non PCO group had normal responding (ovarian diameter between 2 and 3 cm, ovarian volume between 3 and 6.6 cc, AFC 5-12), with regular menstrual cycles and no biochemical or clinical signs of hyperandrogenemia. Patients with other endocrinal derangements like thyroid or prolactin were excluded from the study. Baseline scan was done for all these women on day 3 of the menstrual cycle using 3D US (ultrasound). After acquiring a 3D volume of the ovary, VOCAL (Volume calculation software) was used to define the ovarian volume. Angle of rotation for VOCAL was 15. Then Sono AVC (Automated volume calculation) was used to count the number of antral follicles in each ovary. Antral follicles are the follicles between 2 and 9 mm on day 3 of menstrual cycle. Sono AVC is based on inversion mode and color codes each follicle along with its diameter in all three orthogonal planes (x, y, z), mean diameter and follicular volume. Post processing of Sono AVC was done in all patients to count the number of antral follicles more accurately. Post processing includes manually adding the follicles that were missed on automatic counting, removing the areas that were erroneously counted as antral follicles on automatic counting, cutting the area that was over measured on automatic calculation and merging the areas that were part of the same follicle but was counted as separate follicles. The sum total of antral follicles in both was taken as total AFC. All the scans were done by a single operator on Voluson E8 (GE Healthcare), with 5-9 MHz transvaginal volume probe. Anti mullerian hormone level in patient s blood was measured in all patients on the same day. Measurement of serum AMH levels was performed using AMH/MIS enzyme linked immunosorbent assay kit (Beckman Coulter Immunotech Com., Fullerton, CA). The lowest detection rate limit and intra assay and inter assay coefficients of variation were 1 pmol/l or 0.14 ng/ml, 12.3%, and 14.2%, respectively. The unit of measurement for AMH used was ng/ml. All patients were down regulated by long agonist protocol (Leuprolide acetate 1 mg daily from day 21 of previous cycle and 0.5 mg daily from the day of menstruation till the day of hcg). Recombinant follicle stimulating hormone (rfsh), (Inj. Gonal F, Merck Serono) 150 iu was used for ovulation induction in all patients starting from day 2 of the period. Transvaginal ultrasound scan (TVS) was done on day 6 of stimulation. If at least 2-3 follicles of 10 mm or more were seen, the same dose was continued. If not the dose of rfsh was increased. Stimulation was continued till there were at least 2-3 follicles of 18 mm. These follicles were assessed by color Doppler for their physiological maturity. Follicles when showed flow covering at least 3/4 th of its circumference with resistance index (RI) of <0.48 and peak systolic velocity (PSV) of >10 cm/s, hcg 10,000 was given for ovulation trigger. Ovum pick up was done h after hcg. For both groups the primary end point was number of follicles larger than 12 mm seen on the day of hcg. The final end point was the number of ova retrieved on ovum pick up. In both groups, correlation of AFC and AMH was checked with both these endpoints and correlation of AFC was also checked with AMH. RESULTS In PCO group, the AFC ranged from 25 to 59 with an average of 34 and in non PCO group, the AFC ranged from 11 to 23 follicles with an average of 14. AMH levels in PCO group ranged from 3.39 to 13.4 ng/ml with an average of 6.62 ng/ml and in non PCO group, AMH levels ranged from 0.9 to 2.88 ng/ml with an average of 1.84 ng/ml. Table 1 presents the correlation between AFC and AMH for both groups. Correlation between AFC and AMH in PCO group is 0.46, i.e., higher than the tabulated value (Pearson s correlation), (0.283) at 0.01 Table 1: Correlation of antral follicle count and anti-mullerian hormone Normal Polycystic AFC AFC AMH AMH AFC = Antral follicle count, AMH = Anti-mullerian hormone Journal of Human Reproductive Sciences / Volume 5 / Issue 3 / Sep - Dec
3 level. Similarly for non PCO group, correlation between AFC and AMH is 0.49, which is also higher than the tabulated value (Pearson s correlation), (0.283) at 0.01 level. Table 2 presents the correlation between AFC and follicles of >12 mm diameter on the day of hcg and AMH and follicles >12 mm on the day of hcg for PCO and non PCO groups. Correlation between AFC and follicles of >12 mm on the day of hcg in PCO group is 0.56, that is significant at level (99.9% as per Pearson s correlation coefficient). Similarly for non PCO group, correlation between AFC and follicles larger than 12 mm on the day of hcg is 0.63, which is also significant at 0.01 level. It means AFC is positively correlated with follicles >12 mm on the day of hcg for both groups. Table 2 also presents the correlation between AMH and follicles larger than 12 mm on the day of hcg for both the types of. Correlation between AMH and follicles larger than 12 mm on the day of hcg in PCO group is 0.42, which is significant at 0.01 level. Similarly for non PCO group, correlation between AMH and follicles larger than 12 mm on the day of hcg in non PCO group is 0.47, which is also significant at 0.01 level. This infers that AMH is positively correlated with number of follicles >12 mm on the day of hcg for both. Table 3 shows that comparing the correlation of AFC with number of follicles >12 mm diameter on the day of hcg and AMH and follicles larger than >12 mm on the day of hcg in non PCO group shows a z value of This value is higher than the tabulated one tailed value (0.0823), and also at two tailed (0.1645) value. This indicates that AFC and AMH both correlate with the number of follicles >12 mm on the day of hcg in non PCO group but have different results. It means both the tests need to be performed for estimation of number of follicles >12 mm in diameter available on the day of hcg for non PCO group. In PCO group, comparing the correlation of AFC with follicles >12 mm diameter on the day of hcg and AMH with follicles >12 mm diameter on the day of hcg, a z value of 1.11 is achieved. This value is higher than the tabulated one tailed value and two tailed value This indicates that for PCO group though AFC and AMH can be correlated with the total number of follicles larger than 12 mm diameter on the day of hcg, both have independent for estimation of number of follicles that would grow to a diameter larger than 12 mm on the day of hcg. This means both the tests need to be performed for the estimation of number of follicles >12 mm in diameter available on the day of hcg for PCO group. Results in Table 3 clearly confirm that both AFC and AMH despite having positive and high correlation are yet critical as the level of difference between values of correlation is significant as indicated by z value for both the groups. Table 4 presents the correlation between AFC and AMH and ova retrieved on OPU for both groups. Correlation between AFC and ova retrieved on OPU in PCO group is 0.44, which is significant at 0.01 level, whereas for AMH and ova retrieved on OPU, correlation value is Similarly for non PCO group, correlation between AFC and ova retrieved on OPU in non PCO ovary is 0.50, and correlation for AMH and ova retrieved on OPU the value is This is significant at 0.01 level for PCO also. One can therefore infer that the AFC can be used for estimation of the total number of ova likely to be retrieved on OPU in PCO and non PCO groups. It can also be inferred that AMH is positively correlated with number of ova retrieved on OPU in both groups. One can therefore infer Table 2: Correlation between AFC and follicles >12 mm on the day of hcg and AMH and follicles >12 mm on the day of hcg for PCO and non PCO groups, N=75 Normal AFC >12 mm Polycystic AFC >12 mm AFC AFC >12 mm >12 mm AMH >12 mm AMH >12 mm AMH AMH >12 mm >12 mm AFC = Antral follicle count, AMH = Anti-mullerian hormone Table 3: Z score for difference in correlation of AFC and AMH with number of follicles larger than >12 mm on the day of hcg for non PCO and PCO groups Non PCO >12 mm Test of Polycystic Test of Z value >12 mm Z value AMH * *a AFC Difference *Values for level of : (one tailed test) and (two tailed test) *a Values for level of : (one tailed test) and (two tailed test) Table 4: Correlation of AFC and AMH with ova retrieved on ovum pick up for PCO and non PCO groups, N=75 Normal AFC OPU Polycystic AFC OPU AFC AFC OPU OPU AMH OPU AMH OPU AMH AMH OPU OPU AFC = Antral follicle count, AMH = Anti-mullerian hormone, OPU = Ovum pick up 276 Journal of Human Reproductive Sciences / Volume 5 / Issue 3 / Sep - Dec 2012
4 that AMH also can be used for the estimation of number of ova retrieved on OPU. Comparing the correlation of AFC with number of ova retrieved on OPU and AMH and number of ova retrieved on OPU in non-pco group [Table 5] shows a z value of This value is higher than the tabulated one tailed value , but lower than two tailed value In PCO group, comparing the correlation of AFC to number of ova retrieved on OPU and AMH to number of ova retrieved on OPU, a z value of 0.36 is achieved. This value is almost same as the tabulated one tailed value and lower than two tailed value This indicates that for non PCO group, AFC and AMH do have minimally different but independent for estimating the ova retrieved on OPU, but for PCO group, AFC and AMH do not have independent for assessment of ovarian reserve and AFC only may suffice to estimate the number of ova retrieved on OPU. This infers that in PCO group, AFC only suffices for the estimation of ovarian reserve. For non PCO groups as the z score value is higher than one tailed value, but lower than two tailed value; this infers that though AMH may increase the accuracy of estimation of number of ova retrieved on OPU over AFC, this difference is not highly significant. DISCUSSION Success of any technique for artificial reproduction depends on selection of a correct protocol for ovarian stimulation. This can be decided only by proper assessment of ovarian reserve before commencing ovarian stimulation. Various tests have been tried at different times for assessment of ovarian reserve like S.FSH, AMH, AFC, Inhibin B, etc., Several studies have been done and published at different times assessing these different markers for assessment of ovarian reserve. AMH and AFC have been shown to be the most sensitive ones for assessment of ovarian reserve in these studies. AFC and ovarian volume provide direct measurements of ovarian reserve, while AMH, inhibin B and oestradiol are released from growing follicles and so their levels reflect the size of developing follicle cohort. [4] Table 5: Z score for difference in correlation of AFC and AMH with OPU for non-pco and PCO groups Non PCO OPU Test of Polycystic Test of Z value OPU Z value AMH * *a AFC Difference *Values for level of : (one tailed test) and (two tailed test) *a Values for level of : (one tailed test) and (two tailed test), OPU = Ovum pick up AFC can be reliably and accurately calculated by 3D US. 3D US with SonoAVC was used for the purpose of more accuracy and reproducibility. Inversion mode is most convenient method for counting antral follicles when they are multiple. [5] Number of follicles >12 mm on day of oocyte retrieval correlated significantly with AFC counted by 3D US rather than 2D US. Studies have been done to compare the accuracy and reliability of AFC and AMH for prediction of low response or for prediction of ovarian hyperstimulation. Serum AMH levels have been shown to strongly correlate with the number of antral follicles [6,7] and have appeared to be cycle independent. [8,9] The ROC curves do not suggest a clearly better predictive ability for AMH than for AFC, and the difference was not statistically significant. This implies that the best poor response predictor to date, AFC, [10] has obtained company from a test that may have some crucial advantages. This implies that AFC can predict the response of ovary to stimulation and can be used for selection of individual cycle for ovulation induction, but adding AMH also allows to assess the quality of the resultant ova and embryo. Broer et al. have compared AFC and AMH and have shown that sensitivity and specificity for AMH were 82 and 76%, respectively, and 82 and 80%, respectively, for AFC. Comparison of the summary estimates and ROC curves for AMH and AFC showed no statistical difference in this study. Both AMH and AFC are accurate predictors of excessive response to ovarian hyperstimulation. [11] Another study by Aflatoonian et al. has shown that small AFC and anti müllerian hormone have similar predictive accuracy for high ovarian response with area under curve of and 0.922, respectively. The sensitivity and specificity for prediction of high ovarian response were 89% and 92% for small AFC and 93% and 78% for anti müllerian hormone at the cutoff values of 16 and 34.5 pmol/l, respectively. [12] Still one more study compares AMH and AFC for assessment of ovarian response. Number of retrieved oocytes was statistically significant and correlated with D3 AMH, AFC, DhCG AMH, DhCG inhibin B, FSH, and age (r = 0.885, 0.874, 0.742, 0.732, 0.521, 0.385, respectively). [13] In a metaanalysis by Broer et al., it has been shown that AMH has at least the same level of accuracy and clinical value for the prediction of poor response and non pregnancy as AFC. [14] AMH may provide a more accurate assessment of the follicle pool in young hypergonadotropic patients, especially in the Journal of Human Reproductive Sciences / Volume 5 / Issue 3 / Sep - Dec
5 clinically challenging subgroups of patients with elevated FSH and regular menses (i.e., IOF: incipient ovarian failure) and in hypergonadotropic women with cycle disturbances not fulfilling the POF diagnostic criteria (i.e., TOF: transistional ovarian failure). [15] AFC and AMH are the most significant predictors of poor response to ovarian stimulation. Both alone or in combination have a similar predictive power. Combination of both tests do not significantly increase the predictive power. [16] Comparing AFC and AMH for assessment of ovarian reserve in poor responding has been done in several studies. But assessment of both as predictor for normal response or for hyperstimulation has been done only in a few. Therefore, the two groups PCO and non PCO (normal responding ) were selected for this study. The purpose was to decrease the number of tests that a patient undergoing ART, has to take, to decrease the stress as well as financial burden, without compromising with the information gained. Ultrasound is as such done before starting the ovarian stimulation for ART and AFC is a part of it. The study has shown that both AFC and AMH are equally accurate for assessment of ovarian reserve, in PCO as well as in patients with normal. AFC therefore may be thought of as a single test for assessment of ovarian reserve. CONCLUSION The results suggest that AFC and AMH both correlate with each other but have independent for estimating follicles larger than 12 mm on the day of hcg. But for estimation of ova expected on OPU, the difference of correlation coefficient between AFC and AMH is minimally significant in non PCO and is not significant in PCO group. As the ultimate end result is ova retrieved on OPU, it can be concluded that for both groups, AFC alone may suffice as a test for estimation of ovarian reserve. This is so because the z values for both non PCO as well as PCO group is equal to or below the tabulated one tailed value. ENDNOTE 1. Significance of correlation at 0.01 level is required to be higher than Significance of correlation at 0.01 level is required to be higher than REFERENCES 1. Weenen C. Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Antimullerian hormone expression pattern in human oovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10: Gougeon A, Echochard R, Thalabard JC. Age related changes of the population of human ovarian follicles: Increase in the disappearance rate of nongrowing and early growing follicles in aging women. Biol Reprod 1994;50: BroekmansFJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests of predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12: Hendricks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for prediction of outcome in IVF patients: A comparative meta analysis of ovarian volume and antral follicle count. Fertil Steril 2007;87: Ng EH, Chan CC, Yeung WS, Ho PC. Effect of age on ovarian stromal flow measured by three dimensional ultrasound with power Doppler in Chinese women with proven fertility. Hum Reprod 2004;19: Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Antimullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211: Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, Jong FH, et al. Serum antimullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17: Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, te Velde ER, Broekmans FJ. Antimullerian hormone levels in the spontaneous menstrual cycle do not show sunstantial fluctuation. J Clin Endocrinol Metab 2006;91: La MArca A, Stabile G, Artenisio AC, Volpe A. Serum antimullerian hormone throughout the human menstrual cycle. Hum Reprod 2006;21: Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: A meta analysis and comparision with basal follicle stimulating hormone level. Fertil Steril 2005;83: van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, Fauser BC, et al. Comparison of inter and intra cycle variability of anti Mullerian hormone and antral follicle counts. Hum Reprod 2010;25: Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: Anti mullerian hormone versus small antral follicle count (2 6mm). J Assist Reprod Genet 2009;26: Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. Serum anti Mullerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet 2009;26: Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerain hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91: Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate Booij MJ, Hoek A, Beerendonk CC, et al. Antimullerian hormone, Inhibin B and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009;94: Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Rainne Fenning N. A prospective, comparative analysis of anti mullerian hormone, inhibin B, and three dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril 2010;93:30 9. How to cite this article: Panchal S, Nagori C. Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve. J Hum Reprod Sci 2012;5: Source of Support: Nil, Conflict of Interest: None declared. 278 Journal of Human Reproductive Sciences / Volume 5 / Issue 3 / Sep - Dec 2012
Prognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationAntral follicle count as a predictor of ovarian response
Original article Antral follicle count as a predictor of ovarian response N. Lonegro a, N. Napoli a,*, R. Pesce b and C. Chacón a a Imaging Department, Hospital Italiano de Buenos Aires, Ciudad Autónoma
More informationQuantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques
Ultrasound Obstet Gynecol 2010; 35: 354 360 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7505 Quantitative analysis of antral follicle number and size: a comparison
More informationInternational Journal of Pharma and Bio Sciences ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN ABSTRACT
Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 ENDOCRINE MARKERS AND DECLINE IN REPRODUCTIVE POTENTIAL OF WOMEN BUSHRA FIZA *, 1, 2, RATI MATHUR 2, MAHEEP
More informationResearch Article. Jayakrishnan Krishnakumar 1, Akansha Agarwal 1, Divya Nambiar 1, Shankar Radhakrishnan 2 *
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Krishnakumar J et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2762-2767 www.ijrcog.org pissn 2320-1770 eissn
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationS. DEB*, B. K. CAMPBELL, J. S. CLEWES, C. PINCOTT-ALLEN and N. J. RAINE-FENNING
Ultrasound Obstet Gynecol 2013; 41: 21 222 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI:.02/uog.1122 Intracycle variation in number of antral follicles stratified by size and
More informationUltrasound-based Decision Making on Stimulation Protocol for IVF Cycles
Sonal Panchal, Chaitanya Nagori ORIGINAL SCIENTIFIC ARTICLE 10.5005/jp-journals-10009-1481 Ultrasound-based Decision Making on Stimulation Protocol for IVF Cycles 1 Sonal Panchal, 2 Chaitanya Nagori ABSTRACT
More informationEarly follicular anti-mullerian hormone as a predictor of ovarian response during ICSI cycles
Middle East Fertility Society Journal (2010) 15, 281 287 Middle East Fertility Society Middle East Fertility Society Journal www.mefsjournal.com www.sciencedirect.com ORIGINAL ARTICLE Early follicular
More informationAge-Specific Serum Anti-Mullerian Hormone and Follicle Stimulating Hormone Concentrations in Infertile Iranian Women
Original Article Age-Specific Serum Anti-Mullerian Hormone and Follicle Stimulating Hormone Concentrations in Infertile Iranian Women Alireza Raeissi, M.Sc. 1, Alireza Torki, M.Sc. 1, Ali Moradi, Ph.D.
More informationJMSCR Vol 06 Issue 09 Page September 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i9.53 Role of Anti-Mullerian Hormone
More informationEvaluation of ovarian response prediction according to age and serum AMH levels in IVF cycles: a retrospective analysis
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pillai SM et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3306-3310 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173190
More informationPersonalizing ovarian stimulation for IVF
Personalizing ovarian stimulation for IVF Biljana Popovic-Todorovic MD,PhD Centre for Reproductive Medicine UZ Brussel QuickTime and are needed to see this picture. Controlled ovarian stimulation for IVF/ICSI
More informationThree-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow
Ultrasound Obstet Gynecol 28; 31: 439 444 Published online 1 March 28 in Wiley InterScience (www.interscience.wiley.com). DOI: 1.12/uog.531 Three-dimensional ultrasound improves the interobserver reliability
More informationBiomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology
Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients Scott Nelson Muirhead Chair in Obstetrics & Gynaecology Why do we need to know ovarian response? Anna Sarah Just do IVF and see response
More informationAnti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
ORIGINAL REPORT Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients Ashraf Aleyasin, Marzie Aghahoseini, Sara Mokhtar, and Parvin Fallahi
More informationProspective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity
Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity Adela Rodrıguez-Fuentes, M.D., a Jairo Hernandez, Ph.D.,
More informationAMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF. Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD
AMH CUT-OFF VALUES FOR PREDICTING OVARIAN RESPONSE IN IVF Nguyễn Xuân Hợi, MD, PhD Hoàng Văn Hùng MsC, MD INTRODUCTION Ovarian stimulation is an important process in IVF treatment, aiming at obtain a number
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationAge specific serum anti-müllerian hormone levels in 1,298 Korean women with regular menstruation
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2011;38(2):93-97 Age specific serum anti-müllerian hormone levels in 1,298 Korean women with regular menstruation Ji Hee Yoo, Hye Ok
More informationQuestions. Ultrasound markers of ovarian reserve Modena April 18-19, Your choice is.. Impact study: stop OR tests or Soft catheters??
Ultrasound markers of ovarian reserve Modena April 18-19, 2008 Frank J Broekmans Reproductive Medicine UMC Utrecht Impact study: stop OR tests or Soft catheters?? Stop OR screening, cost reduction 21 euro
More informationHormonal Assays. MATERIALS AND METHODS Experimental Design. Treatment Protocol. Data Acquisition. Data Analysis. Statistical Analysis
The cohort of antral follicles measuring 2 6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-m ullerian hormone and response to controlled ovarian stimulation
More informationAssociation of ovarian reserve with age, BMI and serum FSH level in subfertile women
409 ORIGINAL ARTICLE Association of ovarian reserve with age, BMI and serum FSH level in subfertile women Sarwat Jehan, 1 Sadiqa Syed 2 Abstract Objective: To examine the association of age, body mass
More informationNomogram to predict the number of oocytes retrieved in controlled ovarian stimulation
ORIGINAL ARTICLE http://dx.doi.org/.63/cerm.216.43.2.112 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 216;43(2):112-118 Nomogram to predict the number of oocytes retrieved in controlled ovarian
More informationIndividualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization
WHITE PAPER Individualized Controlled Ovarian Stimulation: Biomarker-Guided Treatment Personalization Author: Antonio La Marca, MD, PhD, Clinica Eugin and University of Modena and Reggio Emilia, Modena,
More informationCorrelation between three assay systems for anti-müllerian hormone (AMH) determination. Li, RHW; Ng, EHY; Wong, BPC; Anderson, RA; Ho, PC; Yeung, WSB
Title Correlation between three assay systems for anti-müllerian hormone (AMH) determination Author(s) Li, RHW; Ng, EHY; Wong, BPC; Anderson, RA; Ho, PC; Yeung, WSB Citation Journal of Assisted Reproduction
More informationThe relationship of serum anti- Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study
Human Reproduction, Vol.0, No.0 pp. 1 7, 2013 doi:10.1093/humrep/det015 Hum. Reprod. Advance Access published February 1, 2013 ORIGINAL ARTICLE Reproductive endocrinology The relationship of serum anti-
More informationArticle Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?
RBMOnline - Vol 16. No 5. 2008 664-670 Reproductive BioMedicine Online; www.rbmonline.com/article/3179 on web 11 March 2007 Article Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality
More informationClinical uses of anti-m ullerian hormone assays: pitfalls and promises
Clinical uses of anti-m ullerian hormone assays: pitfalls and promises Isabelle Streuli, M.D., a Timothee Fraisse, M.D., M.Sc., a Charles Chapron, M.D., b Gerard Bijaoui, M.D., b Paul Bischof, Ph.D., a
More informationReproduction. AMH Anti-Müllerian Hormone. Analyte Information
Reproduction AMH Anti-Müllerian Hormone Analyte Information - 1-2011-01-11 AMH Anti-Müllerian Hormone Introduction Anti-Müllerian Hormone (AMH) is a glycoprotein dimer composed of two 72 kda monomers 1.
More informationFollicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation
Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing
More informationAnti-Mullerian hormone (AMH) as predictor of ovarian reserve
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053
More informationMedicine, Al-Nahrain University
Iraqi JMS Published by Al-Nahrain College of Medicine ISSN 1681-6579 Email: iraqijms@colmed-alnahrain.edu.iq http://www.colmed-alnahrain.edu.iq Relation of Antimüllerian, Follicular Stimulating Hormone
More informationThe ovarian response resulting
Comparison of antim ullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationNormal serum concentrations of anti-müllerian hormone in women with regular menstrual cycles
Reproductive BioMedicine Online (2010) 21, 463 469 www.sciencedirect.com www.rbmonline.com ARTICLE Normal serum concentrations of anti-müllerian hormone in women with regular menstrual cycles A La Marca
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More information(Predictive. value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In
Ovarian Rese erve Lab Tests In (Predictive IVF value) Soheila Ansaripour Fellowship of infertility Ai Avicena Research In nstitute t Case Presentation 29 y/o,primary inf 1.5yr, Hx of irregular menses (
More informationIntra-cycle fluctuations of anti-müllerian hormone in normal women with a regular cycle: a re-analysis
Reproductive BioMedicine Online (2012) 24, 664 669 www.sciencedirect.com www.rbmonline.com ARTICLE Intra-cycle fluctuations of anti-müllerian hormone in normal women with a regular cycle: a re-analysis
More informationMedicine, University of Glasgow, Glasgow, United Kingdom; and c The Fertility Clinic, Odense University Hospital, Odense, Denmark
Does the time interval between antim ullerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization intracytoplasmic sperm injection cycles
More informationIndividualized treatment based on ovarian reserve markers
Individualized treatment based on ovarian reserve markers Prof Dr. Nikolaos P. Polyzos M.D. PhD Professor and Medical Co- Director, Vrije Universiteit Brussel, UZ Brussel, Belgium Professor of Reproduc?ve
More informationSerum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Human Reproduction Vol.23, No.1 pp. 160 167, 2008 Advance Access publication on November 13, 2007 doi:10.1093/humrep/dem254 Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationPredictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
Oehninger et al. Reproductive Biology and Endocrinology (2015) 13:117 DOI 10.1186/s12958-015-0113-1 RESEARCH Open Access Predictive factors for ovarian response in a corifollitropin alfa/gnrh antagonist
More informationAims of this talk. Evaluation & investigation. Basic treatments/options including ovulation induction & Intra uterine Insemination
Basic treatments/options including ovulation induction & Intra uterine Insemination Karen Woodcock Clinical Nurse Specialist/ Nurse Manager Fertility & Assisted Conception Unit Countess of Chester NHS
More informationNGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam
NGUYEN QUOC ANH M.D., M.Sc. Tu Du Hospital Vietnam FULLY AUTOMATED AMH TESTING OF OVARIAN RESPONSE IN IVF NGUYỄN QUỐC ANH MD. Infertility dep. Tudu hospital Index What is AMH? Standard AMH testing Fully
More informationGene expression of follicle-stimulating hormone receptors in granulosa cells in poor ovarian responders
Journal of Physics: Conference Series PAPER OPEN ACCESS Gene expression of follicle-stimulating hormone receptors in granulosa cells in poor ovarian responders To cite this article: P A Iffanolida et al
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationThe emergence of Personalized Medicine protocols for IVF.
Individualising IVF: Introduction to the POSEIDON Concept Introduction The emergence of Personalized Medicine protocols for IVF. Differences between patients: age, ovarian reserve, BMI or presence of ovarian
More informationAntral follicle count in clinical practice: analyzing clinical relevance
CONTROVERSY I Antral follicle count in clinical practice: analyzing clinical relevance Albert Hsu, M.D., Margaret Arny, Ph.D., Alexander B. Knee, M.S., Carrie Bell, M.D., Elizabeth Cook, Ph.D., Amy L.
More informationOriginal Research Article
RATIONALE OF INCORPORATING SERUM ANTI-MULLERIAN HORMONE ESTIMATIONS IN DIAGNOSING PREMATURE OVARIAN FAILURE Pranay Phukan 1, Surajeet Boruah 2 1Associate Professor, Department of Obstetrics and Gynaecology,
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More informationThe Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization
The Significance of Low Anti-Müllerian Hormone Levels in Young Women Undergoing in Vitro Fertilization Caitlin Haswell, M.D., Estil Strawn, Jr., M.D., Aniko Szabo, Ph.D., Joseph Davis, D.O., and Kate D.
More informationAnti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors
Reproductive BioMedicine Online (2010) 20, 42 47 www.sciencedirect.com www.rbmonline.com ARTICLE Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationP. A. Peres Fagundes 1,2, R. Chapon 1,2, P. R. Olsen 2, A. K. Schuster 2, M. M. C. Mattia 2,3 and J. S. Cunha-Filho 1,2,4*
Peres Fagundes et al. Reproductive Biology and Endocrinology (2017) 15:96 DOI 10.1186/s12958-017-0314-x RESEARCH Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile
More informationIOF POI. hypergonadotropic hypogonadism primary ovarian insufficiency POI /premature ovarian failure POF. Van Kasteren. Coulam POI FSH E.
hypergonadotropic hypogonadism primary ovarian insufficiency POI /premature ovarian failure POF Coulam POI Turner Fragile X premutation FSHR NOBOX FOXL etc POI FSH miu/ml AMH AMH AMH FSH / Knauff POI IOF
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationFERTILITY PRESERVATION. Sanghoon Lee & Sinan Ozkavukcu & Elke Heytens & Fred Moy & Rose M. Alappat & Kutluk Oktay
J Assist Reprod Genet (2011) 28:651 656 DOI 10.1007/s10815-011-9567-z FERTILITY PRESERVATION Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes
More informationIVF-ICSI outcome in relation to the antral follicle count. Study population and amount of treatments.
Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries Jan Holte, M.D., Ph.D., a,b Thomas Brodin,
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Serum
More informationThe value of anti-müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophindose adjustments
Human Reproduction, Vol.27, No.6 pp. 1829 1839, 2012 Advanced Access publication on April 3, 2012 doi:10.1093/humrep/des101 ORIGINAL ARTICLE Reproductive endocrinology The value of anti-müllerian hormone
More informationSonoAVC WHITE PAPER. Introduction. gehealthcare.com
SonoAVC Adela Rodriguez-Fuentes, MD; Jairo Hernandez, PhD; Angela Palumbo, PhD Centro de Asistencia a la Reproducción Humana de Canarias (FIVAP) WHITE PAPER Introduction Imaging methods are constantly
More informationAnti-Müllerian hormone as a predictor of pregnancy following IVF
Reproductive BioMedicine Online (2013) 26, 247 252 www.sciencedirect.com www.rbmonline.com ARTICLE Anti-Müllerian hormone as a predictor of pregnancy following IVF Priya Bhide a, *, Anil Gudi a, Amit Shah
More informationIs the measurement of anti-müllerian hormone essential?
REVIEW C URRENT OPINION Is the measurement of anti-müllerian hormone essential? Taner Usta a and Engin Oral b Purpose of review Over the past decade, a large number of studies examining the multiple roles
More informationAssociation between Anti-Mullerian Hormone and Ovarian Response and Pregnancy in Polycystic Ovary Syndrome Patients
http://www.ijwhr.net Open Access doi 10.15296/ijwhr.2019.08 Original Article International Journal of Women s Health and Reproduction Sciences Vol. 7, No. 1, January 2019, 49 53 ISSN 2330-4456 Association
More informationUtility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation Syndrome
Research Article imedpub Journals http://www.imedpub.com/ Annals of Clinical and Laboratory Research DOI: 10.21767/2386-5180.1000167 Utility of Estradiol as a Predictive Marker of Ovarian Hyper Stimulation
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationInhibin B and anti-mullerian hormone: markers of ovarian response in IVF/ICSI patients?
BJOG: an International Journal of Obstetrics and Gynaecology November 2004, Vol. 111, pp. 1248 1253 DOI: 10.1111/j.1471-0528.2004.00452.x Inhibin B and anti-mullerian hormone: markers of ovarian response
More informationArticle Anti-Müllerian hormone as a predictor of IVF outcome
RBMOnline - Vol 14. No 5. 2007 602-610 Reproductive BioMedicine Online; www.rbmonline.com/article/2720 on web 23 March 2007 Article Anti-Müllerian hormone as a predictor of IVF outcome Dharmawijaya Nayanananda
More informationAnti-Müllerian Hormone Levels in the Follicular Fluid of the Preovulatory Follicle: A Predictor for Oocyte Fertilization and Quality of Embryo
ORIGINAL ARTICLE Obstetrics & Gynecology http://dx.doi.org/1.3346/jkms.214.29.9.1266 J Korean Med Sci 214; 29: 1266-127 Anti-Müllerian Hormone Levels in the Follicular Fluid of the Preovulatory Follicle:
More informationIndividualization of the FSH starting dose in IVF/ ICSI cycles using the antral follicle count
La Marca et al. Journal of Ovarian Research 2013, 6:11 RESEARCH Open Access Individualization of the FSH starting dose in IVF/ ICSI cycles using the antral follicle count Antonio La Marca 1*, Valentina
More informationAntral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
BJOG: an International Journal of Obstetrics and Gynaecology October 2005, Vol. 112, pp. 1384 1390 DOI: 10.1111/j.1471-0528.2005.00670.x Antral follicle count, anti-mullerian hormone and inhibin B: predictors
More informationThe Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (8), Page
The Egyptian Journal of Hospital Medicine (January 2018) Vol. 70 (8), Page 1278-1288 Anti-Mullerian Hormone: An Indicator for the Severity of Polycystic Ovarian Syndrome Yehia Abd-Elsalam Wafa 1, Mohamed
More informationA randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count
DOI: 10.1111/j.1471-0528.2010.02545.x www.bjog.org Fertility and assisted reproduction A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders
More informationOriginal Investigation. 94 Endocrine Oncology and Metabolism. Jovanovska et al
Original Investigation Sensitivity and specificity of anti-mülerian hormone in the diagnosis of polycystic ovary syndrome in a macedonian population of women of reproductive age: a cross-sectional study
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationANTI-MÜLLERIAN HORMONE (AMH) AS A USEFUL MARKER IN DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
General Endocrinology ANTI-MÜLLERIAN HORMONE (AMH) AS A USEFUL MARKER IN DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME Laura Leonte 1,2, M. Coculescu 3, S. Radian 3, Simona Fica 4, Andra Caragheorgheopol 3, B.
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationSonography-based Automated Volume Count (SonoAVC): an efficient and reproducible method of follicular assessment
GE Healthcare Sonography-based Automated Volume Count (SonoAVC): an efficient and reproducible method of follicular assessment Todd D. Deutch, MD Clinical Reproductive Endocrinology and Infertility Fellow
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationENDOCRINE CHARACTERISTICS OF ART CYCLES
ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine
More informationCORRELATIONS BETWEEN ANTI-MÜLLERIAN HORMONE, INHIBIN B, AND ACTIVIN A IN FOLLICULAR FLUID IN IVF/ICSI PATIENTS FOR ASSESSING
604 EU RO PE AN JOUR NAL OF MED I CAL RE SEARCH December 14, 2007 Eur J Med Res (2007) 12: 604-608 I. Holzapfel Publishers 2007 CORRELATIONS BETWEEN ANTI-MÜLLERIAN HORMONE, INHIBIN B, AND ACTIVIN A IN
More informationSerum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients
J Assist Reprod Genet (2009) 26:383 389 DOI 10.1007/s10815-009-9332-8 ASSISTED REPRODUCTION Serum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients Cheng-Hsuan Wu & Yu-Ching
More informationWHY INVESTIGATE FOR INFERTILITY
WHY INVESTIGATE FOR INFERTILITY Intrauterine Insemination 1 About this booklet This series of booklets has been developed and written with the support of leading fertility clinics across Australia, and
More informationWhat is the value of anti-müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
Knez et al. Reproductive Biology and Endocrinology (2015) 13:58 DOI 10.1186/s12958-015-0049-5 RESEARCH Open Access What is the value of anti-müllerian hormone in predicting the response to ovarian stimulation
More informationOvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters
Journal of Ovarian Research This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. OvAge: a new methodology
More informationLan Wang, Yiqing Zhao, Xiyuan Dong, Kai Huang, Rui Wang, Licheng Ji, Ya Wang, Hanwang Zhang
Int J Clin Exp Med 2015;8(2):2711-2718 www.ijcem.com /ISSN:1940-5901/IJCEM0003568 Original Article Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian
More informationStudentoppgave. Veileder: Dr. med Jan Mellembakken, overlege Kvinneklinikken, Rikshospitalet. Profesjonsstudiet i Medisin
Studentoppgave Maintained number of oocytes with advanced age in PCOS women during IVF treatment compared to controls Mirjam Kilen Veileder: Dr. med Jan Mellembakken, overlege Kvinneklinikken, Rikshospitalet
More informationArticle Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status
RBMOnline - Vol 12 No 6. 2006 695-703 Reproductive BioMedicine Online; www.rbmonline.com/article/2207 on web 3 April 2006 Article Anti-Müllerian hormone: clinical insights into a promising biomarker of
More informationOvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters
Venturella et al. Journal of Ovarian Research (2015) 8:21 DOI 10.1186/s13048-015-0149-z RESEARCH Open Access OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic
More informationManish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group
Manish Banker Nova IVI Fertility Pulse Women's Hospital Gujarat, India Declared receipt of grants; member of a company advisory board, board of director or similar group The Indian point of view Manish
More informationEXCEPTIONAL DIAGNOSTICS FOR REPRODUCTIVE DISEASE STATE MANAGEMENT. Anti-Müllerian Hormone (AMH)
EXCEPTIONAL DIAGNOSTICS FOR REPRODUCTIVE DISEASE STATE MANAGEMENT Anti-Müllerian Hormone (AMH) Table of Contents» Introduction... 3» Biosynthesis... 3» Physiological Function... 4 Fetal Stage... 4 Postnatal
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/80097
More informationREPRODUCTIVE ENDOCRINOLOGY
FERTILITY AND STERILITY VOL. 77, NO. 2, FEBRUARY 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY
More informationAnti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization
Original Article Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization Ruma Satwik, Mohinder Kochhar, Shweta M Gupta, Abha
More informationThe Clinical Role of Anti-Mullerian Hormone (AMH) in Assessing Ovarian Reserve among Polycystic Ovary Syndrome
Available online at www.ijpcr.com International Journal of Pharmaceutical and Clinical Research 2013; 5(3): 114-121 Research Article ISSN- 0975 1556 The Clinical Role of Anti-Mullerian Hormone (AMH) in
More information